| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615
The aim of this study was to determine the effect of high levels of free fatty acids (FFA) and/or hyperglycemia on hepatic glycogenolysis and gluconeogenesis. Intralipid was infused peripherally in 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence (FFA + HG) or absence (FFA + EuG) of hyperglycemia. In the control studies, Intralipid was not infused, and euglycemia (EuG) or hyperglycemia (HG) was maintained. Insulin and glucagon were clamped at basal levels in all four groups. The arterial blood glucose level increased by 50% in the HG and FFA + HG groups. It did not change in the EuG and FFA + EuG groups. Arterial plasma FFA increased by ~140% in the FFA + EuG and FFA + HG groups but did not change significantly either in the EuG or HG groups. Arterial glycerol levels increased by ~150% in both groups. Overall (3-h) net hepatic glycogenolysis was 196 ± 26 mg/kg in the EuG group. It decreased by 96 ± 20, 82 ± 16, and 177 ± 22 mg/kg in the HG, FFA + EuG, and FFA + HG groups, respectively. Overall (3-h) hepatic gluconeogenic flux was 128 ± 22 mg/kg in the EuG group, but it was suppressed by 30 ± 9 mg/kg in response to hyperglycemia. It was increased by 59 ± 12 and 56 ± 10 mg/kg in the FFA + EuG and FFA + HG groups, respectively. In conclusion, an increase in plasma FFA and glycerol significantly inhibited hepatic glycogenolysis and markedly stimulated hepatic gluconeogenesis.
free fatty acid; hyperglycemia; glycogenolysis; gluconeogenesis
This article has been cited by other articles:
|
|
 |
|
  S. Satapati, T. He, T. Inagaki, M. Potthoff, M. E. Merritt, V. Esser, D. J. Mangelsdorf, S. A. Kliewer, J. D. Browning, and S. C. Burgess Partial Resistance to Peroxisome Proliferator-Activated Receptor-{alpha} Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism Diabetes, August 1, 2008; 57(8): 2012 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ross, P. Y.T. Wang, M. Chari, C. K.L. Lam, L. Caspi, H. Ono, E. D. Muse, X. Li, R. Gutierrez-Juarez, P. E. Light, et al. Hypothalamic Protein Kinase C Regulates Glucose Production Diabetes, August 1, 2008; 57(8): 2061 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Weickert, C. v. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M. A. Osterhoff, F. Isken, J. Spranger, B. R. Landau, et al. A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1078 - E1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Champagne, D. S. Houser, and D. E. Crocker Glucose metabolism during lactation in a fasting animal, the northern elephant seal Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R1129 - R1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. M. W. van Kempen, S. N. van der Crabben, M. T. Ackermans, E. Endert, J. H. Kok, and H. P. Sauerwein Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E723 - E730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Guy, D. Sandoval, M. A. Richardson, D. Tate, P. J. Flakoll, and S. N. Davis Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E178 - E186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Cleasby, N. Dzamko, B. D. Hegarty, G. J. Cooney, E. W. Kraegen, and J.-M. Ye Metformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms Diabetes, December 1, 2004; 53(12): 3258 - 3266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, M. Frolich, M. T. Ackermans, H. P. Sauerwein, A. F. Cohen, A. E. Meinders, and H. Pijl Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E63 - E68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Moore, S. Satake, M. Lautz, S. A. Soleimanpour, D. W. Neal, M. Smith, and A. D. Cherrington Nonesterified Fatty Acids and Hepatic Glucose Metabolism in the Conscious Dog Diabetes, January 1, 2004; 53(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca Mechanisms of the free fatty acid-induced increase in hepatic glucose production Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Staehr, O. Hother-Nielsen, B. R. Landau, V. Chandramouli, J. J. Holst, and H. Beck-Nielsen Effects of Free Fatty Acids Per Se on Glucose Production, Gluconeogenesis, and Glycogenolysis Diabetes, February 1, 2003; 52(2): 260 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Bernard, M.-A. Thil, and R. Groscolas Lipolytic and metabolic response to glucagon in fasting king penguins: phase II vs. phase III Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R444 - R454. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
